1. Home
  2. ARCT vs SPTN Comparison

ARCT vs SPTN Comparison

Compare ARCT & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • SPTN
  • Stock Information
  • Founded
  • ARCT 2013
  • SPTN 1917
  • Country
  • ARCT United States
  • SPTN United States
  • Employees
  • ARCT N/A
  • SPTN 17000
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • ARCT Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • ARCT Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • ARCT 487.0M
  • SPTN 630.9M
  • IPO Year
  • ARCT N/A
  • SPTN N/A
  • Fundamental
  • Price
  • ARCT $15.88
  • SPTN $18.69
  • Analyst Decision
  • ARCT Strong Buy
  • SPTN Hold
  • Analyst Count
  • ARCT 8
  • SPTN 1
  • Target Price
  • ARCT $61.00
  • SPTN $20.00
  • AVG Volume (30 Days)
  • ARCT 405.9K
  • SPTN 248.1K
  • Earning Date
  • ARCT 03-06-2025
  • SPTN 02-12-2025
  • Dividend Yield
  • ARCT N/A
  • SPTN 4.71%
  • EPS Growth
  • ARCT N/A
  • SPTN 9.92
  • EPS
  • ARCT N/A
  • SPTN 1.33
  • Revenue
  • ARCT $160,399,000.00
  • SPTN $9,532,883,000.00
  • Revenue This Year
  • ARCT $7.33
  • SPTN N/A
  • Revenue Next Year
  • ARCT $4.71
  • SPTN $2.15
  • P/E Ratio
  • ARCT N/A
  • SPTN $14.06
  • Revenue Growth
  • ARCT N/A
  • SPTN N/A
  • 52 Week Low
  • ARCT $14.30
  • SPTN $17.30
  • 52 Week High
  • ARCT $45.00
  • SPTN $23.00
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 41.74
  • SPTN 56.59
  • Support Level
  • ARCT $16.03
  • SPTN $17.77
  • Resistance Level
  • ARCT $17.95
  • SPTN $18.66
  • Average True Range (ATR)
  • ARCT 1.29
  • SPTN 0.40
  • MACD
  • ARCT -0.07
  • SPTN 0.11
  • Stochastic Oscillator
  • ARCT 10.29
  • SPTN 96.19

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: